Clinical Research (Excluding Clinical Trials) 2019
DOI: 10.1158/1538-7445.sabcs18-3008
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 3008: PSMA glycosylation and aggressive prostate cancer progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…As a result of these advances, targeted glycomic research continuously expands the implication of glycosylation in physiological processes such as cell signaling (11)(12)(13)(14), host-pathogen interaction (15)(16)(17)(18), and immune response (11,(19)(20)(21), with significant revelations provided in connection to human disease. Recent evaluations demonstrating the importance of glycosylation in neurodegenerative diseases (22,23), diabetes (24,25), and cancer (26)(27)(28) promote further interest in glycomic investigation to reveal potential biomarkers and unambiguous symptomatic protein profiles. As focus shifts from glycomic discovery and characterization to that of glycan expression levels and minute perturbations in site occupancy, the need for robust and efficient glycan and glycopeptide quantitative strategies steadily grows.…”
mentioning
confidence: 99%
“…As a result of these advances, targeted glycomic research continuously expands the implication of glycosylation in physiological processes such as cell signaling (11)(12)(13)(14), host-pathogen interaction (15)(16)(17)(18), and immune response (11,(19)(20)(21), with significant revelations provided in connection to human disease. Recent evaluations demonstrating the importance of glycosylation in neurodegenerative diseases (22,23), diabetes (24,25), and cancer (26)(27)(28) promote further interest in glycomic investigation to reveal potential biomarkers and unambiguous symptomatic protein profiles. As focus shifts from glycomic discovery and characterization to that of glycan expression levels and minute perturbations in site occupancy, the need for robust and efficient glycan and glycopeptide quantitative strategies steadily grows.…”
mentioning
confidence: 99%